Skip to content
About
Clinical Trials
Resources
Contact
About
Clinical Trials
Resources
Contact
Trial Type: Ewing's Sarcoma
LS-P-RACES(JP04)
Protocol Addendum J1S-MC-JP04 A Randomized, Open-Label, Phase 2 Study Evaluating Abemaciclib in Combination with Irinotecan and Temozolomide in Participants with Relapsed or Refractory Ewing’s Sarcoma.
Status: Open
Trial Type:
Ewing's Sarcoma
Contact: Jennifer Welch, MD
jwelch@brownhealth.org
